Compare DexCom, Inc. (DXCM) vs EOG Resources Inc (EOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs EOG Resources Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while EOG Resources Inc trades at $148.16 (market cap $77.90B). The key difference: EOG Resources Inc is far larger — about 2.4× DexCom, Inc.'s market cap, and EOG Resources Inc pays a 2.75% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and EOG Resources Inc for 59 Days on average.
| DXCM | EOG | |
|---|---|---|
Market Cap | $31.86B | $77.90B |
Volume | 3,607,070 | 2,930,386 |
Sector | Health | Energy |
52-Week High | $92.34 | $153.74 |
52-Week Low | $54.84 | $101.78 |
Typical Hold Time | 62 Days | 59 Days |
Enterprise Value | $31.32B | $81.24B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
EOG Resources trades at $148.16, up 2.74% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 25.81% net income margin and consistent earnings beats, though revenue declined to $22.58B in 2025. Recent CFO transition and upcoming Q3 earnings on November 6, 2026 are key developments. Technical indicators show the stock trading near pivot point resistance at $148 with RSI suggesting potential overbought conditions.
EOG presents a compelling value opportunity with attractive valuation multiples (P/E 11.56, EV/EBITDA 5.84) and strong analyst support (59% buy rating, $164.77 target). Risks include oil price volatility and recent insider selling. The company's disciplined capital allocation and 5% oil volume growth guidance support long-term upside potential despite near-term revenue pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →
